Autor: Firma T-knife

T-knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

2. August 20212. August 2021 Firma T-knifeForschung und Entwicklungcancer, cd8, cell, cells, clinical, ctas, hla, hutcr, mage, MICE, patients, tcr, tcrs, versant, with

T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for solid tumor patients, today announced the successful completion of a $110 million Series B financing. The financing was led by Fidelity Management & Research Company, Mehr

T-knife Therapeutics Announces the Appointment of Megan Baierlein as Chief Operating Officer

12. Juli 202113. Juli 2021 Firma T-knifeForschung und Entwicklungcancer, cell, clinical, company, mage, patients, pharmaceutical, platform, prior, soloway, tcr, therapeutics, treatment, tumor, with

T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for solid tumor patients, today announced the appointment of Megan Baierlein as chief operating officer. “We are excited to welcome Megan to our executive leadership team,” Mehr